Application and Impact of Population Pharmacokinetics in the Assessment of Antiretroviral Pharmacotherapy
- 1 January 2005
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 44 (6), 591-625
- https://doi.org/10.2165/00003088-200544060-00003
Abstract
No abstract availableKeywords
This publication has 130 references indexed in Scilit:
- Mathematical Analysis of Antiretroviral Therapy Aimed at HIV-1 Eradication or Maintenance of Low Viral LoadsJournal of Theoretical Biology, 1998
- EfavirenzDrugs, 1998
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 1997
- Decay characteristics of HIV-1-infected compartments during combination therapyNature, 1997
- Anti-viral Drug Treatment: Dynamics of Resistance in Free Virus and Infected Cell PopulationsJournal of Theoretical Biology, 1997
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995
- Population Pharmacokinetic Analysis of Didanosine (2′,3′‐Dideoxyinosine) Plasma Concentrations Obtained in Phase I Clinical Trials in Patients with AIDS or AIDS‐Related ComplexThe Journal of Clinical Pharmacology, 1992
- Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1980
- Estimation of population characteristics of pharmacokinetic parameters from routine clinical dataJournal of Pharmacokinetics and Biopharmaceutics, 1977